Functional, biochemical, and morphological hepatobiliary effects in rats chronically exposed to a steroidal antiandrogen

Toxicology and Applied Pharmacology

Volumn 137, Issue 1, 1996, Pages 23-33

  Descotes, Gérard ^a,d   Osman, Hanan ^b   Gallas, Jean François ^a   Penacchio, Evelyne ^a   Moreau, Christine ^c  

^a SANOFI   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Dept of Preclinical Biostatistics   (United States)

^d INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; DRUG METABOLITE; ZANOTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT INJURY; BILIARY EXCRETION; CHOLESTASIS; CHRONIC TOXICITY; CONTROLLED STUDY; DRUG METABOLISM; ENZYME INDUCTION; FEMALE; LIVER WEIGHT; MACROPHAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORCHIECTOMY; RAT; SEX DIFFERENCE;

EID: 0029926362     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0053     Document Type: Article

References (35)

1. Berger, B. M., Naadimuthu, A., Boddy, A., Fisher, H. A., McConnell, J. D., Milam, D., Mobley, D., and Rajfer, J. (1995). The effects of zanoterone, a steroidal androgen receptor antagonist, in men with benign prostatic hyperplasia. J. Urol. 194, 150-154.
2. Conney, A. H. (1967). Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317-366.
3. Cornelius, C. E. (1991). Liver function tests in the differential diagnosis of hepatotoxicity. In Hepatotoxicology (R. G. Meeks, S. D. Harrison, and R. J. Bull, Eds.), pp. 181-213. CRC Press, Boca Raton, FL.
4. Descotes, G., Gallas, J. F., Reid, A., Penacchio, E., and Moreau, C. (1993). Evidence of hepatic enzyme induction in rats by zanoterone, a novel steroidal androgen receptor antagonist. Pharmacol. Toxicol. 73(Supp. II), 112.
5. Drew, R., and Priestly, B. G. (1979). Choleretic and cholestatic effects of infused bile salts in the rat. Experientia 35, 809-811.
6. Einarsson, K., Gustafsson, J. A., and Stenberg, A. (1973). Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids. J. Biol. Chem. 248, 4987-4996.
7. Frater, Y., Brady, A., Lock, E. A., and De Matteis, F. (1993). Formation of N-methyl protoporphyrin in chemically-induced protoporphyria. Studies with a novel porphyrogenic agent. Arch. Toxicol. 67, 179-185.
8. Gambert, C., Lallemant, C., Archambault, A., Maume, B. F., and Padieu, P. (1979). Assessment of serum cholesterol by two methods: Gas-liquid chromatography on a capillary column and chemical ionization-mass fragmentography with isotopic dilution of (3,4-13C) cholesterol as internal standard. J. Chromatogr. Biomed. Appl. 162, 1-6.
9. Gumucio, J. J., and Valdivieso, V. D. (1971). Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology 61, 339-344.
10. Gustafsson, J. A., and Stenberg, A. (1974). Irreversible androgenic programming at birth of microsomal and soluble rat liver enzymes active on 4-androstene-3,17-dione and 5α-androstane-3α,17β-diol. J. Biol. Chem. 249, 711-718.
11. Javitt, N. B., and Emerman, S. (1968). Effect of sodium taurolithocholate on bile flow and bile acid excretion. J. Clin. Invest. 47, 1002-1014.
12. Juniewicz, P. E., McCarty, M., Lemp, B. M., Barbolt, T. A., Shaw, C., Hollenbauch, D. M., Winneker, R. C., Reel, J. R., and Batzold, F. H. (1990). The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs. Endocrinology 126, 2625-2634.
13. Juniewicz, P. E., Fetrow, N., Marinelli, J., Wolf, M., Young, E., Lamb, J., and Isaacs, J. T. (1991). Evaluation of WIN 49596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer. Prostate 18, 105-115.
14. Kennedy, C. D., Rudewicz, P. J., Xu, Z. X., Newton, J. F., Baker, J. F., Rodger, C. A., Berger, B. M., VonRoemeling, R. W., Stack, R. F., and Johnson, J. A. (1994). Pharmacokinetics and metabolism of the androgen receptor antagonist zanoterone in normal human males. ISSX Proc. 6, 89.
15. Kossor, D. C., Meunier, P. C., Handler, J. A., Sozio, R. S., and Goldstein, R. S. (1993). Temporal relationship of changes in hepatobiliary function and morphology in rats following α-naphthylisothiocyanate (ANIT) administration. Toxicol. Appl. Pharmacol. 119, 108-114.
16. Kritchevsky, D., Staple, E., Rabinowitz, J., and Whitehouse, M. W. (1961). Differences in cholesterol oxidation and biosynthesis in liver of male and female rats. Am., J. Physiol. 200, 519-522.
17. Kuipers, F., Hardonk, M. J., Vonk, R. J., and Van der Meer, R. (1992). Bile secretion of sulfated glycolithocholic acid is required for its cholestatic action in rats. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25), G267-G273.
18. Matilla, A., and Molland, E. A. (1974). A light and electron microscopic study of the liver in a case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice. J. Clin. Pathol. 27, 698-709.
19. Meyers, M., Slikker, W., and Vore, M. (1981). Steroid D-ring glucuronides: Characterization of a new class of cholestatic agents in the rat. J. Pharmacol. Exp. Ther. 218, 63-73.
20. Miyai, K., Richardson, A. L., Mayr, W. W., and Javitt, N. B. (1977). Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. Effects of lithocholic, 3β-hydroxy-5-cholenoic, cholic and dehydrocholic acids. Lab. Invest. 36, 249-258.
21. Molino, G., Cavanna, A., Biondi, A. M., Macri, G., Urigu, S., and Ugazio, G. (1982). Bromsulphalein (BSP) kinetics in the rat: A new approach in evaluating experimental hepatotoxicity. Int. Arch. Occup. Environ. Health 51, 73-79.
22. Plaa, G. L., and Priestly, B. G. (1977). Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol. Rev. 28, 207-273.
23. Priestly, B. G., Côté, M. G., and Plaa, G. L. (1971). Biochemical and morphological parameters of taurolithocholate-induced cholestasis. Can. J. Physiol. Pharmacol. 49, 1078-1091.
24. Ritz, M. A., Descotes, G., and Roberts, A. E. (1993). Effects of zanoterone, a steroidal androgen receptor antagonist, on monooxygenation of testosterone, ethoxycoumarin and ethoxyresorufin and glucuronidation of p-nitrophenol in rats. ISSX Proc. 4, 106.
25. Roberts, R. J., Klaasen, C. D., and Plaa, G. L. (1967). Maximum biliary excretion of bilirubin and sulfobromophthalein during anesthesia-induced alteration of rectal temperature. Proc. Soc. Exp. Biol. Med. 125, 313-316.
26. Sipes, I. G., and Gandolfi, A. J. (1991). Biotransformation of toxicants. In Casarett and Doull's Toxicology. The Basic Science of Poisons (M. O. Amdur, J. Doull, and C. D. Klaassen, Eds.), 4th ed., pp. 88-126. Pergamon Press, New York.
27. Snyder, B. W., Winneker, R. C., and Batzold, F. H. (1989). Endocrine profile of WIN 49596 in the rat: A novel androgen receptor antagonist. J. Steroid Biochem. 33, 1127-1132.
28. Turley, S. D., and Dietschy, J. M. (1979). Regulation of biliary cholesterol hepatic output in the rat: Dissociation from the rate of hepatic cholesterol synthesis, the size of the hepatic cholesteryl ester pool, and the hepatic uptake of chylomicron cholesterol. J. Lipid Res. 20, 923-934.
29. Turley, S. D., and Dietschy, J. M. (1982). Cholesterol metabolism and excretion. In The Liver: Biology and Pathobiology (I. Arias, H. Popper, D. Schachter, and D. A. Shafritz, Eds.), pp. 467-492. Raven Press, New York.
30. Turley, S. D., and Dietschy, J. M. (1984). Modulation of the stimulatory effect of pregnenolone-16 alpha-carbonitrile on biliary cholesterol output in the rat by manipulation of the rate of hepatic cholesterol synthesis. Gastroenterology 87, 284-292.
31. Vore, M. (1991). Mechanisms of cholestasis. In Hepatotoxicology (R. G. Meeks, S. D. Harrison, and R. J. Bull, Eds.), pp. 525-568. CRC Press, Boca Raton, FL.
32. Wang, G., Stacey, N. H., and Earl, J. (1990). Determination of individual bile acids in serum by high performance liquid chromatography. Biomed. Chromatogr. 4, 136-140.
33. Winneker, R. C., Wagner, M. M., and Batzold, F. H. (1989). Studies on the mechanism of action of WIN 49596: A steroidal androgen receptor antagonist. J. Steroid Biochem. 33, 1133-1138.
34. Zimmerman, C. L., Lyer, K. R., Faudskar, A. L., and Remmel, R. P. (1993). Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5′-O-glucuronide in rat bile. Drug. Metab. Dispos. 21, 902-910.
35. Zsigmond, G., and Solymoss, B. (1972). Effect of spironolactone, pregnenolone-16α-carbonitrile and cortisol on the metabolism and biliary excretion of sulfobromophthalein and phenol-3,6-dibromphthalein disulfonate in rats. J. Phamacol. Exp. Ther. 183, 499-507.